引用本文:陈 科1 许亚梅1 白 桦2 朱陵群3 倪 磊4.恶性淋巴瘤中医规范化诊治探讨[J].世界中医药,2014,9(04):. |
|
恶性淋巴瘤中医规范化诊治探讨 |
Exploration to Standardized Diagnosis and Treatment of Malignant Lymphoma with Chinese Medicine |
投稿时间:2014-02-07 |
DOI:10.3969/j.issn.1673-7202.2014.04.034 |
中文关键词: 恶性淋巴瘤 证侯要素 中医治疗 |
English Keywords:Malignant lymphoma Elements factors TCM treatment |
基金项目:高等学校博士学科点专项科研基金资助项目(编号:20120013120005) |
|
摘要点击次数: 1588 |
全文下载次数: 1948 |
中文摘要: |
中医药在恶性淋巴瘤的治疗中发挥着重要作用,但目前仍存在缺乏有广泛共识的中医诊疗指南及规范,临床研究总体水平和转化能力有待提高等问题。本文通过分析上述问题的原因,提出初步解决办法,即以总结证侯要素、规范基础证型、减毒增效为切入点,对疾病的中医证候要素、证候诊断标准、证型演变规律、证候分布规律、治法及用药规律进行总结,为淋巴瘤证候的标准化研究及中医临床路径提供基础,并使基础研究成果转化于临床实践,从而形成恶性淋巴瘤的中医规范化诊治指南,探索中医规范化诊治思路。 |
English Summary: |
Though traditional Chinese medicine (TCM) plays an important role in the treatment of malignant lymphoma there are still some problems to be overcome, mainly on lack of the guideline and standard of TCM diagnosis and treatment on a broad consensus, lower overall level of clinical research and transformation ability, et al. By analyzing the causes of the above problems, a preliminary solution has been proposed. Through summarization of syndrome facotrs, standardization of basis syndromes, attenuated efficiency to explore new thoughts of TCM diagnosis and treatment. |
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|